Cargando…

Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432

OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Yoshihito, Takei, Hidefumi, Tachibana, Keisei, Nakazato, Yoko, Tanaka, Ryota, Nagashima, Yasushi, Watanabe, Kazuhiro, Seki, Reisuke, Shinohara, Takao, Kondo, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047981/
https://www.ncbi.nlm.nih.gov/pubmed/29434153
http://dx.doi.org/10.2169/internalmedicine.9637-17
_version_ 1783340018004131840
author Morimoto, Yoshihito
Takei, Hidefumi
Tachibana, Keisei
Nakazato, Yoko
Tanaka, Ryota
Nagashima, Yasushi
Watanabe, Kazuhiro
Seki, Reisuke
Shinohara, Takao
Kondo, Haruhiko
author_facet Morimoto, Yoshihito
Takei, Hidefumi
Tachibana, Keisei
Nakazato, Yoko
Tanaka, Ryota
Nagashima, Yasushi
Watanabe, Kazuhiro
Seki, Reisuke
Shinohara, Takao
Kondo, Haruhiko
author_sort Morimoto, Yoshihito
collection PubMed
description OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: The clinical data of 94 patients who underwent pleurodesis with OK-432 were retrospectively analyzed. Patients who developed chest pain (indicated by a record of rescue pain medication) and/or fever (a recorded temperature of >38℃) were identified. A logistic regression analysis was performed to determine the risk factors for these complications. RESULTS: Rescue medication for chest pain was required by 43.6% of the patients and 40.4% developed pyrexia after pleurodesis with OK-432. The univariate analysis showed that the likelihood of requiring rescue medication for chest pain was significantly increased in patients of <70 years of age (p=0.028) and in those who were not premedicated with a nonsteroidal anti-inflammatory drug (NSAID; p=0.003). Age <70 years (adjusted odds ratio 2.97, 95% confidence interval 1.10-8.00, p=0.031) and a lack of premedication with an NSAID (adjusted odds ratio 4.21, 95% confidence interval 1.47-12.04, p=0.007) remained significant factors in a multivariate analysis. The absence of NSAID premedication was the only statistically significant risk factor for fever in the univariate analysis (p=0.034). The multivariate analysis revealed no significant risk factors for fever. CONCLUSION: The results of the present study suggest that premedication with an NSAID might be useful for preventing the chest pain caused by pleurodesis with OK-432. Furthermore, caution is advised when managing chest pain in adults of <70 years of age. Prospective studies should be performed to further investigate this issue.
format Online
Article
Text
id pubmed-6047981
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-60479812018-07-17 Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432 Morimoto, Yoshihito Takei, Hidefumi Tachibana, Keisei Nakazato, Yoko Tanaka, Ryota Nagashima, Yasushi Watanabe, Kazuhiro Seki, Reisuke Shinohara, Takao Kondo, Haruhiko Intern Med Original Article OBJECTIVE: In Japan, pleurodesis is often performed using OK-432. However, OK-432 may cause severe chest pain and fever. The risk factors for these complications are unclear. The aim of this study was to identify the risk factors for chest pain and fever caused by pleurodesis with OK-432. METHODS: The clinical data of 94 patients who underwent pleurodesis with OK-432 were retrospectively analyzed. Patients who developed chest pain (indicated by a record of rescue pain medication) and/or fever (a recorded temperature of >38℃) were identified. A logistic regression analysis was performed to determine the risk factors for these complications. RESULTS: Rescue medication for chest pain was required by 43.6% of the patients and 40.4% developed pyrexia after pleurodesis with OK-432. The univariate analysis showed that the likelihood of requiring rescue medication for chest pain was significantly increased in patients of <70 years of age (p=0.028) and in those who were not premedicated with a nonsteroidal anti-inflammatory drug (NSAID; p=0.003). Age <70 years (adjusted odds ratio 2.97, 95% confidence interval 1.10-8.00, p=0.031) and a lack of premedication with an NSAID (adjusted odds ratio 4.21, 95% confidence interval 1.47-12.04, p=0.007) remained significant factors in a multivariate analysis. The absence of NSAID premedication was the only statistically significant risk factor for fever in the univariate analysis (p=0.034). The multivariate analysis revealed no significant risk factors for fever. CONCLUSION: The results of the present study suggest that premedication with an NSAID might be useful for preventing the chest pain caused by pleurodesis with OK-432. Furthermore, caution is advised when managing chest pain in adults of <70 years of age. Prospective studies should be performed to further investigate this issue. The Japanese Society of Internal Medicine 2018-02-09 2018-06-15 /pmc/articles/PMC6047981/ /pubmed/29434153 http://dx.doi.org/10.2169/internalmedicine.9637-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Morimoto, Yoshihito
Takei, Hidefumi
Tachibana, Keisei
Nakazato, Yoko
Tanaka, Ryota
Nagashima, Yasushi
Watanabe, Kazuhiro
Seki, Reisuke
Shinohara, Takao
Kondo, Haruhiko
Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title_full Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title_fullStr Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title_full_unstemmed Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title_short Risk Factors for Chest Pain and Fever in Patients Undergoing Pleurodesis with OK-432
title_sort risk factors for chest pain and fever in patients undergoing pleurodesis with ok-432
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047981/
https://www.ncbi.nlm.nih.gov/pubmed/29434153
http://dx.doi.org/10.2169/internalmedicine.9637-17
work_keys_str_mv AT morimotoyoshihito riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT takeihidefumi riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT tachibanakeisei riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT nakazatoyoko riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT tanakaryota riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT nagashimayasushi riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT watanabekazuhiro riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT sekireisuke riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT shinoharatakao riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432
AT kondoharuhiko riskfactorsforchestpainandfeverinpatientsundergoingpleurodesiswithok432